PT Pyridam Farma Tbk

0
ISX:PYFA (Indonesia)  
Rp 161.00 (-3.59%) Jan 14
On watch
At Loss
P/B:
1.58
Market Cap:
Rp 1.81T ($ 111.02M)
Enterprise V:
Rp 5.19T ($ 318.28M)
Volume:
43.48M
Avg Vol (2M):
40.52M
Warning! GuruFocus detected 8 Severe warning signs with PYFA. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
43.48M
Market Cap Rp:
1.81T
Market Cap $:
111.02M
At Loss
Avg Vol (2M):
40.52M
Enterprise Value Rp:
5.19T
Enterprise Value $:
318.28M
PB Ratio:
1.58
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

PT Pyridam Farma Tbk

ISIN : ID1000075609
https://www.pyfa.co.id
Jl. Gen. Sudirman No. Kav. 21, Sinarmas MSIG Tower 12th Floor, RT.10/RW.1, Kuningan, Karet, Setiabudi District, South Jakarta City, Jakarta, IDN, 12920
Compare
Compare
ISX:DVLAISX:MERKISX:PEHAISX:TSPCZTSXTER:MRKNSE:SUNPHARMALSE:HLNTSE:4502XSWX:GALDXTAE:TEVANSE:DIVISLABXSWX:SDZVTRSSZSE:000538NBIXBOM:543904BOM:500124NSE:TORNTPHARMHKSE:03692
Traded in other countries / regions
PYFA.Indonesia
IPO Date
2001-10-16
Description
PT Pyridam Farma Tbk is an Indonesia-based company, engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through the following segments: Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. The company derives maximum revenue from Pharmaceutical Products and Toll Manufacturing Services. The company's products include consumer health, Derma, prescription, and biomedilab.

Financial Strength

3/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset 0.2
Debt-to-Equity 3.24
Debt-to-EBITDA -54.92
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.31
Distress
Grey
Safe
Beneish M-Score 0.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

6/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 36.3
3-Year EBITDA Growth Rate -22.5
3-Year FCF Growth Rate -166.8
3-Year Book Growth Rate 31.3

Momentum Rank

6/10
Name Current Vs Industry Vs History
5-Day RSI 14.56
9-Day RSI 21.24
14-Day RSI 26.7
6-1 Month Momentum % 116.51
12-1 Month Momentum % 0.84

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.74
Quick Ratio 0.52
Cash Ratio 0.22
Days Inventory 126.66
Days Sales Outstanding 94.16
Days Payable 61.03

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -88.05

Profitability Rank

7/10
Name Current Vs Industry Vs History
Gross Margin % 27.38
Operating Margin % -3.25
Net Margin % -18.33
FCF Margin % -5.24
ROE % -34.17
ROA % -7.22
ROIC % -1.3
3-Year ROIIC % -2.75
ROC (Joel Greenblatt) % -6.28
ROCE % -4.26
Years of Profitability over Past 10-Year 9

GF Value Rank

3/10
Name Current Vs Industry Vs History
Shiller PE Ratio 21.82
PS Ratio 0.73
PB Ratio 1.58
EV-to-EBIT -53.19
EV-to-EBITDA -73.37
EV-to-Revenue 3.86
EV-to-FCF -74.61
Price-to-Projected-FCF 17.52
Price-to-Median-PS-Value 1.5
Earnings Yield (Greenblatt) % -1.88
FCF Yield % -3.89
Forward Rate of Return (Yacktman) % 4.51

Financials

ISX:PYFA's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

PT Pyridam Farma Tbk Executives

Details

GF Value: Rp150.99

ISX:PYFA

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil Rp) 1,343,422.616
EPS (TTM) (Rp) -46.066
Beta 0.52
Volatility % 148.71
14-Day RSI 26.7
14-Day ATR (Rp) 17.323578
20-Day SMA (Rp) 202.25
12-1 Month Momentum % 0.84
52-Week Range (Rp) 81 - 338
Shares Outstanding (Mil) 11,236.68

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PT Pyridam Farma Tbk Filings

Filing Date Document Date Form
No Filing Data

PT Pyridam Farma Tbk Stock Events

Financials Calendars
Event Date Price(Rp)
No Event Data

PT Pyridam Farma Tbk Frequently Asked Questions

What is PT Pyridam Farma Tbk(ISX:PYFA)'s stock price today?
The current price of ISX:PYFA is Rp161.00. The 52 week high of ISX:PYFA is Rp338.00 and 52 week low is Rp81.00.
When is next earnings date of PT Pyridam Farma Tbk(ISX:PYFA)?
The next earnings date of PT Pyridam Farma Tbk(ISX:PYFA) is .
Does PT Pyridam Farma Tbk(ISX:PYFA) pay dividends? If so, how much?
PT Pyridam Farma Tbk(ISX:PYFA) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.